Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 6
2021 8
2022 2
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Improvement of Symptoms and Cardiac Magnetic Resonance Abnormalities in Patients with Post-Acute Sequelae of SARS-CoV-2 Cardiovascular Syndrome (PASC-CVS) after Guideline-Oriented Therapy.
Gyöngyösi M, Hasimbegovic E, Han E, Zlabinger K, Spannbauer A, Riesenhuber M, Hamzaraj K, Bergler-Klein J, Hengstenberg C, Kammerlander A, Kastl S, Loewe C, Beitzke D. Gyöngyösi M, et al. Among authors: hasimbegovic e. Biomedicines. 2023 Dec 14;11(12):3312. doi: 10.3390/biomedicines11123312. Biomedicines. 2023. PMID: 38137533 Free PMC article.
A CircRNA-miRNA-mRNA Network for Exploring Doxorubicin- and Myocet-Induced Cardiotoxicity in a Translational Porcine Model.
Mester-Tonczar J, Einzinger P, Hasimbegovic E, Kastner N, Schweiger V, Spannbauer A, Han E, Müller-Zlabinger K, Traxler-Weidenauer D, Bergler-Klein J, Gyöngyösi M, Lukovic D. Mester-Tonczar J, et al. Among authors: hasimbegovic e. Biomolecules. 2023 Nov 27;13(12):1711. doi: 10.3390/biom13121711. Biomolecules. 2023. PMID: 38136582 Free PMC article.
Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome.
Gyöngyösi M, Lukovic D, Mester-Tonczar J, Zlabinger K, Einzinger P, Spannbauer A, Schweiger V, Schefberger K, Samaha E, Bergler-Klein J, Riesenhuber M, Nitsche C, Hengstenberg C, Mucher P, Haslacher H, Breuer M, Strassl R, Puchhammer-Stöckl E, Loewe C, Beitzke D, Hasimbegovic E, Zelniker TA. Gyöngyösi M, et al. Among authors: hasimbegovic e. NPJ Vaccines. 2023 Sep 29;8(1):145. doi: 10.1038/s41541-023-00739-2. NPJ Vaccines. 2023. PMID: 37773184 Free PMC article.
Plasma Small Extracellular Vesicle Cardiac miRNA Expression in Patients with Ischemic Heart Failure, Randomized to Percutaneous Intramyocardial Treatment of Adipose Derived Stem Cells or Placebo: Subanalysis of the SCIENCE Study.
Traxler D, Dannenberg V, Zlabinger K, Gugerell A, Mester-Tonczar J, Lukovic D, Spannbauer A, Hasimbegovic E, Kastrup J, Gyöngyösi M. Traxler D, et al. Among authors: hasimbegovic e. Int J Mol Sci. 2023 Jun 26;24(13):10647. doi: 10.3390/ijms241310647. Int J Mol Sci. 2023. PMID: 37445825 Free PMC article. Clinical Trial.
Identification of Gene Expression Signatures for Phenotype-Specific Drug Targeting of Cardiac Fibrosis.
Lukovic D, Hasimbegovic E, Winkler J, Mester-Tonczar J, Müller-Zlabinger K, Han E, Spannbauer A, Traxler-Weidenauer D, Bergler-Klein J, Pavo N, Goliasch G, Batkai S, Thum T, Zannad F, Gyöngyösi M. Lukovic D, et al. Among authors: hasimbegovic e. Int J Mol Sci. 2023 Apr 18;24(8):7461. doi: 10.3390/ijms24087461. Int J Mol Sci. 2023. PMID: 37108624 Free PMC article.
A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome.
Kovarik JJ, Bileck A, Hagn G, Meier-Menches SM, Frey T, Kaempf A, Hollenstein M, Shoumariyeh T, Skos L, Reiter B, Gerner MC, Spannbauer A, Hasimbegovic E, Schmidl D, Garhöfer G, Gyöngyösi M, Schmetterer KG, Gerner C. Kovarik JJ, et al. Among authors: hasimbegovic e. iScience. 2023 Jan 20;26(1):105717. doi: 10.1016/j.isci.2022.105717. Epub 2022 Dec 5. iScience. 2023. PMID: 36507225 Free PMC article.
A Sneak-Peek into the Physician's Brain: A Retrospective Machine Learning-Driven Investigation of Decision-Making in TAVR versus SAVR for Young High-Risk Patients with Severe Symptomatic Aortic Stenosis.
Hasimbegovic E, Papp L, Grahovac M, Krajnc D, Poschner T, Hasan W, Andreas M, Gross C, Strouhal A, Delle-Karth G, Grabenwöger M, Adlbrecht C, Mach M. Hasimbegovic E, et al. J Pers Med. 2021 Oct 22;11(11):1062. doi: 10.3390/jpm11111062. J Pers Med. 2021. PMID: 34834414 Free PMC article.
21 results